Articles tagged with "biologic drugs"

20 Years of RA Data: First-Line Biologic & Targeted Synthetic DMARD Trends

September 1, 2021 • By Michele B. Kaufman, PharmD, BCGP

Biologics in Rheumatology: Revolution & Perspectives

December 8, 2020 • By Lara C. Pullen, PhD

Biologic Treatment Recommendations for Rheumatic Disease Patients Who Contract COVID-19

July 7, 2020 • By Thomas R. Collins

Biologic Spending & Price Trends

January 28, 2020 • By Arthritis & Rheumatology

Investigators Assess Infection Risk with RA Biologics

August 29, 2018 • By Thomas R. Collins

Ustekinumab Has Longer Efficacy Duration than TNFIs for Plaque Psoriasis

March 28, 2017 • By Michele B. Kaufman, PharmD, BCGP

When Starting Biologics for RA, Disease Severity Predicts Likelihood of Remission

March 22, 2017 • By Reuters Staff

Physician’s Choice: Factors That Influence First- & Second-Line Biologic Therapy in RA Patients

February 20, 2017 • By Michele B. Kaufman, PharmD, BCGP

U.S. Supreme Court Declines to Hear Biologic Drug Patent Fight

December 12, 2016 • By Brendan Pierson

Hidradenitis Suppurativa Can Complicate Biologic Therapy

April 13, 2016 • By Will Boggs, MD